Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea

Hun Gyu Hwang (Gumi, Republic of Korea), Hun Gyu Hwang, Myung Shin Kim, Gune Il Lim, Won-Il Choi

Source: International Congress 2016 – Acute pulmonary embolism
Session: Acute pulmonary embolism
Session type: Thematic Poster
Number: 2465
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hun Gyu Hwang (Gumi, Republic of Korea), Hun Gyu Hwang, Myung Shin Kim, Gune Il Lim, Won-Il Choi. Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea. Eur Respir J 2016; 48: Suppl. 60, 2465

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
Source: Eur Respir J 2016; 48: 1369-1376
Year: 2016



Complications of anticoagulant therapy in patients with pulmonary thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 604s
Year: 2007

Direct oral anticoagulants and venous thromboembolism
Source: Eur Respir Rev 2016; 25: 295-302
Year: 2016



Efficiency of r-TPA therapy in major venous thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 83s
Year: 2007

Guided duration of anticoagulation after unprovoked venous thromboembolism using D-dimer testing
Source: Eur Respir J 2016; 47:1313-1314
Year: 2016


Efficacy and safety of systemic and prolonged low-dose thrombolysis in thromboembolic disease
Source: Eur Respir J 2002; 20: Suppl. 38, 478s
Year: 2002

Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review
Source: Eur Respir Rev, 27 (150) 180094; 10.1183/16000617.0094-2018
Year: 2018



Effectiveness of thrombolytic therapy in pulmonary thromboembolism
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007


Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial
Source: Eur Respir J, 51 (1) 1701202; 10.1183/13993003.01202-2017
Year: 2018



Fixed or weight-adjusted dosis of enoxaparin as prophylaxis for venous thromboembolism in acutelly ill medical patients
Source: Eur Respir J 2004; 24: Suppl. 48, 273s
Year: 2004

Venous thrombo-embolism prophylaxis
Source: Annual Congress 2009 - PG18 Practical clinical lessons in pulmonary vascular medicine: a case-based approach
Year: 2009


A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE)
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019

Evaluation of VTE-BLEED for predicting intracranial or fatal bleeding in stable anticoagulated patients with venous thromboembolism
Source: Eur Respir J, 51 (4) 1800077; 10.1183/13993003.00077-2018
Year: 2018



Prospects for the prevention and treatment of venous thromboembolism
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=155
Year: 2004

Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Treatment and prevention of cancer-associated venous thromboembolism
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021


Incidence of venous thromboembolism 8-weeks post discharge in hospitalised medical patients not receiving thrombo-prophylaxis
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Anticoagulant treatment of venous thromboembolism: established and new oral agents, remaining questions
Source: International Congress 2014 – Current controversies in the management of acute pulmonary embolism
Year: 2014



Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010

The evaluation of medication adherence in patients with pulmonary thromboembolism
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018